StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings

Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patients

TORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announces that its Clinical Business, Care Oncology, has added the fourth of a series of new program offerings. Pinky Jimenez-Agrawal, with WellnessScript, will provide mental health support specifically for cancer patients at twice-monthly clinics. The first clinic is Thursday November 9, 2023 and is open to patients globally.

Screening to find cancer early is the first pillar (Aristotle^TM); adjunctive treatment with the Care Oncology Protocol is the second; nutritional guidance tailored to the type and stage of the cancer is the third pillar and mental health support is the fourth pillar. The Company believes that these additional offerings present an excellent entry point for cancer patients to be introduced to the full Care Oncology program.

"Mental Health support is a key component of medical care today - the problems that a medical diagnosis brings, in todays very unsettled world, are further exacerbated by receiving a diagnosis of cancer. The subsequent days, months and even years might be filled with anxiety. Cancer, naturally, carries a lot of negative associations" commented James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. "Ms Jimenez-Agrawal, through the SupportACT clinics, will assist our patients not only at the time of diagnosis, but also at any point in their journey whether during treatment or in remission. The clinics are designed as drop-in sessions, focussed around topics, with discussion afterwards" he added.

One in three patients with cancer have challenges with mental health: up to 25% of cancer survivors suffer from depression and up to 45% with anxiety. 30.2% of breast cancer patients suffer from depression which, unsupported, results in a 25% increase in mortality rate. Source: Epidemiol Psychiatric Sciences. 2020; 29: e86. Published online 2020 Jan 9. doi: 10.1017/S2045796019000866 PMCID: PMC7214708 PMID: 31915100 Mental health care in oncology. Contemporary perspective on the psychosocial burden of cancer and evidence-based interventions R. Caruso1 and W. Breitbart2